Medicine - Infectious Diseases

Projects

Projects per year 1984 2004 2006 2007 2018 2024

• 30 Active
• 303 Finished

Projects per year

Search results

• Finished

  COVID-19: Significance of Fc properties and functions in antibody responses against SARS-CoV-2

  Hioe, C.

  U.S. Department of Veterans Affairs

  1/01/22 → 31/12/22

  Project: Research

  • SARS Virus 100%
  • Antibodies 41%
  • Antibody Formation 37%
  • Saliva 31%
  • Immunoglobulin Isotypes 21%

• ConProject-004

  Garcia-Sastre, A.

  National Institute of Allergy and Infectious Diseases

  1/01/22 → 31/12/22

  Project: Research

• ConProject-005

  Garcia-Sastre, A.

  National Institute of Allergy and Infectious Diseases

  1/01/22 → 31/12/22

  Project: Research

• Single cell transcriptomics of HIV persistence and latency

  Chen, B. B. K. & Chen, B.

  National Institute of Allergy and Infectious Diseases

  19/03/21 → 28/02/23

  Project: Research

  • HIV 100%
  • T-Lymphocytes 48%
  • HIV Infections 20%
  • Animal Models 16%
  • Cell Lineage 16%

• Impact of gender affirming hormone therapy on immune modulation and HIV infection in transgender young adults

  Chang, T. & Chang, T. L.

  National Institute of Allergy and Infectious Diseases

  4/03/21 → 28/02/23

  Project: Research

  • Transgender Persons 100%
  • young adult 84%
  • gender 74%
  • HIV Infections 66%
  • Young Adult 61%

• Project 3 - Ex vivo immune profiling of dengue viruses and vaccines

  Fernandez-Sesma, A.

  National Institute of Allergy and Infectious Diseases

  15/02/21 → 31/05/21

  Project: Research

  • Dengue Vaccines 100%
  • Dengue Virus 77%
  • National Institute of Allergy and Infectious Diseases (U.S.) 66%
  • SARS Virus 64%
  • Pandemics 46%

• Project 2: Susceptibility of Lung Cancer Cells to SARS- CoV-2 Infection and Antibody-Mediated Neutralization

  Garcia-Sastre, A.

  National Cancer Institute

  30/09/20 → 29/09/21

  Project: Research

  • SARS Virus 100%
  • Lung Neoplasms 61%
  • Antibodies 27%
  • Infections 26%
  • Lung 14%

• HIV immune evasion and escape through T cell virological synapses

  Chen, B.

  National Institute of Allergy and Infectious Diseases

  14/09/20 → 31/08/21

  Project: Research

  • Immune Evasion 100%
  • Synapses 90%
  • HIV 59%
  • T-Lymphocytes 47%
  • Broadly Neutralizing Antibodies 18%

• Biologic consequences of HIV-1 interaction with bacteria

  Hioe, C.

  National Institute of Allergy and Infectious Diseases

  14/09/20 → 31/08/22

  Project: Research

  • HIV-1 100%
  • Bacteria 58%
  • Viruses 17%
  • E coli fimH protein 15%
  • Mannose-Binding Lectins 11%

• Dissecting the mechanisms of HIV-1 infection and inflammatory signaling in human lymphoid tissue

  Swartz, T.

  National Institute of Allergy and Infectious Diseases

  1/08/20 → 31/07/21

  Project: Research

  • HIV-1 100%
  • HIV Infections 91%
  • Lymphoid Tissue 90%
  • Palatine Tonsil 57%
  • Research Personnel 25%

• Project-003

  Fernandez-Sesma, A. & Harris, E.

  National Institute of Allergy and Infectious Diseases

  1/06/20 → 31/05/21

  Project: Research

  • SARS Virus 100%
  • Coronavirus 85%
  • Innate Immunity 62%
  • Permissiveness 51%
  • Palatine Tonsil 39%

• Core G - IOF Management Core

  Garcia-Sastre, A.

  National Institute of Allergy and Infectious Diseases

  1/06/20 → 31/05/22

  Project: Research

  • Immunology 100%

• Core A - Administrative Core

  Fernandez-Sesma, A.

  National Institute of Allergy and Infectious Diseases

  1/06/20 → 31/05/22

  Project: Research

  • principal investigators 100%
  • research programs 96%
  • communication (human) 95%
  • accountability 44%
  • Anas 37%

• Project 3 - Ex vivo immune profiling of dengue viruses and vaccines

  Fernandez-Sesma, A.

  National Institute of Allergy and Infectious Diseases

  1/06/20 → 31/05/22

  Project: Research

  • Dengue Virus 100%
  • Dengue Vaccines 97%
  • Virus Diseases 38%
  • Innate Immunity 34%
  • Dengue 25%

• Project 3 - Ex vivo immune profiling of dengue viruses and vaccines

  Fernandez-Sesma, A.

  National Institute of Allergy and Infectious Diseases

  1/06/20 → 31/05/21

  Project: Research

  • Dengue Vaccines 100%
  • Dengue Virus 77%
  • SARS Virus 76%
  • Coronavirus 65%
  • Innate Immunity 48%

• Using immune complex vaccines to optimize antibody responses to HIV Env

  Hioe, C. & Hessell, A. J.

  National Institute of Allergy and Infectious Diseases

  12/03/20 → 28/02/21

  Project: Research

  • Antigen-Antibody Complex 100%
  • Vaccines 59%
  • Antibody Formation 59%
  • HIV 47%
  • Crowns 34%

• CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)

  Garcia-Sastre, A.

  1/10/19 → 30/09/20

  Project: Research

  • Orthomyxoviridae 100%
  • Human Influenza 91%
  • Cross Protection 70%
  • Pandemics 52%
  • Virulence 43%

• CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)

  Garcia-Sastre, A.

  1/10/19 → 30/09/20

  Project: Research

  • Orthomyxoviridae 100%
  • Human Influenza 91%
  • Cross Protection 70%
  • Pandemics 52%
  • Virulence 43%

• CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)

  Garcia-Sastre, A.

  1/10/19 → 30/09/20

  Project: Research

  • Orthomyxoviridae 100%
  • Human Influenza 91%
  • Cross Protection 70%
  • Pandemics 52%
  • Virulence 43%

• CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS

  Garcia-Sastre, A.

  1/10/19 → 30/09/20

  Project: Research

  • Human Influenza 100%
  • Orthomyxoviridae 73%
  • Cross Protection 51%
  • Pandemics 38%
  • Virulence 31%

• CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS

  Garcia-Sastre, A.

  1/10/19 → 30/09/20

  Project: Research

  • Human Influenza 100%
  • Orthomyxoviridae 73%
  • Cross Protection 51%
  • Pandemics 38%
  • Virulence 31%

• CEIRS - SARS-CoV-2 RESEARCH

  Garcia-Sastre, A.

  1/10/19 → 30/09/20

  Project: Research

  • SARS Virus 100%
  • Cross Protection 96%
  • Viruses 90%
  • Pandemics 72%
  • Virulence 59%

• CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)

  Garcia-Sastre, A.

  1/10/19 → 30/09/20

  Project: Research

  • Orthomyxoviridae 100%
  • Human Influenza 91%
  • Cross Protection 70%
  • Pandemics 52%
  • Virulence 43%

• Reversal of HIV Cognitive Disease in Mice Employing Broadly Specific T Cell Vaccines

  Potash, M. J. & Volsky, D. J.

  National Institute of Neurological Disorders and Stroke

  30/09/19 → 31/08/21

  Project: Research

  • HIV 100%
  • Vaccines 86%
  • T-Lymphocytes 71%
  • Viruses 31%
  • Vaccination 22%

• Defining the role of pseudouridine modifications in HIV biology

  Simon, V. & Pan, T.

  National Institute of Allergy and Infectious Diseases

  1/08/19 → 31/07/20

  Project: Research

  • Pseudouridine 100%
  • HIV 62%
  • RNA 37%
  • pseudouridine synthases 12%
  • HIV Infections 11%

• Development of broadly neutralizing antibodies to treat hantavirus infections

  Alvarez, R. A.

  National Institute of Allergy and Infectious Diseases

  3/05/19 → 30/04/20

  Project: Research

  • Hantavirus 100%
  • Hantavirus Infections 82%
  • Broadly Neutralizing Antibodies 70%
  • Hemorrhagic Fever with Renal Syndrome 31%
  • Biological Products 12%

• RespiDART: Frontiers in Drug Development against Respiratory Viruses

  Schinazi, R. F. & Palese, P.

  National Institute of Allergy and Infectious Diseases

  1/11/18 → 31/10/19

  Project: Research

  • Viruses 100%
  • Drug Development 86%
  • Antiviral Agents 45%
  • Posters 45%
  • Vaccines 39%

• CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS

  Garcia-Sastre, A.

  1/10/18 → 30/09/19

  Project: Research

  • Human Influenza 100%
  • Orthomyxoviridae 73%
  • Cross Protection 51%
  • Pandemics 38%
  • Virulence 31%

• CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)

  Garcia-Sastre, A.

  1/10/18 → 30/09/19

  Project: Research

  • Orthomyxoviridae 100%
  • Human Influenza 91%
  • Cross Protection 70%
  • Pandemics 52%
  • Virulence 43%

• CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS

  Garcia-Sastre, A.

  1/10/18 → 30/09/19

  Project: Research

  • Human Influenza 100%
  • Orthomyxoviridae 73%
  • Cross Protection 51%
  • Pandemics 38%
  • Virulence 31%

• CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)

  Garcia-Sastre, A.

  1/10/18 → 30/09/19

  Project: Research

  • Orthomyxoviridae 100%
  • Human Influenza 91%
  • Cross Protection 70%
  • Pandemics 52%
  • Virulence 43%

• CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)

  Garcia-Sastre, A.

  1/10/18 → 30/09/19

  Project: Research

  • Orthomyxoviridae 100%
  • Human Influenza 91%
  • Cross Protection 70%
  • Pandemics 52%
  • Virulence 43%

• CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)

  Garcia-Sastre, A.

  1/10/18 → 30/09/19

  Project: Research

  • Orthomyxoviridae 100%
  • Human Influenza 91%
  • Cross Protection 70%
  • Pandemics 52%
  • Virulence 43%

• Antibody-dependent cellular phagocytosis by human breastmilk leukocytes: impact of antibody class, stage of lactation, and target size

  Powell, R.

  National Institute of Child Health and Human Development

  21/09/18 → 31/08/19

  Project: Research

  • Phagocytosis 100%
  • Immunoglobulin Isotypes 99%
  • Lactation 98%
  • HIV 76%
  • Leukocytes 71%

• OPTIMIZING LUNG CANCER SCREENING IN WORLD TRADE CENTER RESCUE AND RECOVERY WORKERS

  Sigel, K. & Wisnivesky, J. P. J. P.

  National Institute for Occupational Safety and Health

  1/07/18 → 30/06/21

  Project: Research

  • Lung Neoplasms 100%
  • Early Detection of Cancer 79%
  • Tomography 67%
  • Cost-Benefit Analysis 66%
  • Occupational Groups 49%

• OPTIMIZING LUNG CANCER SCREENING IN WORLD TRADE CENTER RESCUE AND RECOVERY WORKERS

  Sigel, K. & Wisnivesky, J. P. J. P.

  National Institute for Occupational Safety and Health

  1/07/18 → 30/06/21

  Project: Research

  • Lung Neoplasms 100%
  • Early Detection of Cancer 79%
  • Tomography 67%
  • Cost-Benefit Analysis 66%
  • Occupational Groups 49%

• Preventing CD4+ T memory cells from becoming HIV reservoirs

  Simon, V. V. A. & Simon, V.

  National Institute of Allergy and Infectious Diseases

  18/05/18 → 30/04/22

  Project: Research

  • HIV 100%
  • T-Lymphocytes 29%
  • Proviruses 25%
  • Interleukin-15 24%
  • Infections 23%

• Role of IFNe in immune modulation and HIV infection

  Chang, T. & Chang, T. L.

  National Institute of Allergy and Infectious Diseases

  1/03/18 → 28/02/23

  Project: Research

  • HIV Infections 100%
  • HIV 80%
  • Estrogens 68%
  • Interferons 59%
  • Semen 24%

• Core A - Administrative Core

  Garcia-Sastre, A.

  National Institute of Allergy and Infectious Diseases

  20/01/18 → 31/12/21

  Project: Research

  • biology 100%
  • director 99%
  • contagious disease 77%
  • training opportunities 48%
  • staffing 41%

• Core D - Data Management and Bioinformatics Core

  Pache, L. & Garcia-Sastre, A.

  National Institute of Allergy and Infectious Diseases

  20/01/18 → 31/12/21

  Project: Research

  • Bioinformatics 100%
  • Information management 90%
  • Visualization 23%
  • Websites 13%
  • Data structures 12%

• Core C - Modeling Core

  Sekaly, R. P. & Garcia-Sastre, A.

  National Institute of Allergy and Infectious Diseases

  20/01/18 → 31/12/21

  Project: Research

  • Biomarkers 100%
  • Medicine 80%
  • Signal transduction 59%
  • Metabolites 54%
  • Pathogens 54%

• Project 1 - Host-virus networks regulating flu replication and host responses in vivo

  Garcia-Sastre, A.

  National Institute of Allergy and Infectious Diseases

  20/01/18 → 31/12/21

  Project: Research

  • Orthomyxoviridae 100%
  • Viruses 81%
  • Virus Diseases 69%
  • Influenza A virus 41%
  • Biomarkers 36%

• Core B - Technology Core

  Krogan, N. & Garcia-Sastre, A.

  National Institute of Allergy and Infectious Diseases

  20/01/18 → 31/12/21

  Project: Research

  • Proteins 100%
  • Metabolites 99%
  • Viruses 85%
  • Metabolomics 55%
  • Pathogens 49%

• UNDERSTANDING TH-MONOCYTE INTERACTIONS IN HIV INFECTION

  Hioe, C.

  U.S. Department of Veterans Affairs

  1/01/18 → 31/12/21

  Project: Research

• UNDERSTANDING TH-MONOCYTE INTERACTIONS IN HIV INFECTION

  Hioe, C.

  U.S. Department of Veterans Affairs

  1/01/18 → 31/12/21

  Project: Research

  • Antigen-Presenting Cells 100%
  • HIV 86%
  • Monocytes 78%
  • HIV Infections 72%
  • Th17 Cells 61%

• Understanding Th-monocyte interactions in HIV infection

  Hioe, C.

  U.S. Department of Veterans Affairs

  1/01/18 → 31/12/21

  Project: Research

  • HIV Infections 100%
  • Monocytes 94%
  • HIV 78%
  • Antigen-Presenting Cells 77%
  • Th17 Cells 47%

• UNDERSTANDING TH-MONOCYTE INTERACTIONS IN HIV INFECTION

  Hioe, C.

  U.S. Department of Veterans Affairs

  1/01/18 → 31/12/21

  Project: Research

  • Antigen-Presenting Cells 100%
  • HIV 86%
  • Monocytes 78%
  • HIV Infections 72%
  • Th17 Cells 61%

• Ending HIV/AIDS among People Who Use Drugs: Overcoming Challenges

  Perlman, D.

  National Institute on Drug Abuse

  1/01/18 → 31/01/22

  Project: Research

  • Acquired Immunodeficiency Syndrome 100%
  • HIV 94%
  • Communicable Diseases 65%
  • Epidemiology 60%
  • Research Personnel 53%

• CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)

  Garcia-Sastre, A.

  1/10/17 → 30/09/18

  Project: Research

  • Orthomyxoviridae 100%
  • Human Influenza 91%
  • Cross Protection 70%
  • Pandemics 52%
  • Virulence 43%

• CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS

  Garcia-Sastre, A.

  1/10/17 → 30/09/18

  Project: Research

  • Human Influenza 100%
  • Orthomyxoviridae 73%
  • Cross Protection 51%
  • Pandemics 38%
  • Virulence 31%